Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Autologous Whole Tumor Cell Vaccination Early After Allogeneic Stem Cell Transplantation Elicits Anti-Tumor T Cell Responses in Patients with Advanced Chronic Lymphocytic Leukemia (CLL)

Blood (2012) 120 (21): 1892.

https://doi.org/10.1182/blood.V120.21.1892.1892

Published: 2012

Journal Articles

CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

Asad Bashey, Bridget Medina, Sue Corringham, Mildred Pasek, Ewa Carrier, Linda Vrooman, Israel Lowy, Scott R. Solomon, Lawrence E. Morris, H. Kent Holland, James R. Mason, Edwin P. Alyea, Robert J. Soiffer, Edward D. Ball

Blood (2009) 113 (7): 1581–1588.

https://doi.org/10.1182/blood-2008-07-168468

Published: 2009

Journal Articles

GM-CSF Secreting Leukemia Cell Vaccination after Allogeneic Reduced Intensity Hematopoietic Stem Cell Transplantation for Advanced Myeloid Malignancies

Vincent Ho, MD, Glenn Dranoff, MD, Haesook Kim, PhD, Matthew Vanneman, Mildred Pasek, Corey Cutler, MD, John Koreth, MBBS, Edwin Alyea, MD, Joseph H Antin, MD, Ritz Jerome, MD, Robert J Soiffer, MD

Blood (2008) 112 (11): 825.

https://doi.org/10.1182/blood.V112.11.825.825

Published: 2008

Journal Articles

Clinical Trial of Therapeutic Blockade of CTLA4 with Ipilimumab in Patients with Relapse of Malignancy Following Allogeneic Hematopoietic Transplantation.

Asad Bashey, MD, PhD, Bridget Medina, Sue Corringham, RN, Mildred Pasek, Ewa Carrier, MD, Linda Vrooman, RN, Howard Streicher, MD, Israel Lowy, MD, Scott R. Solomon, MD, Lawrence E. Morris, MD, Kent Holland, MD, James R. Mason, MD, Robert J. Soiffer, MD, Edward D. Ball, MD

Blood (2007) 110 (11): 1646.

https://doi.org/10.1182/blood.V110.11.1646.1646

Published: 2007

Journal Articles

GM-CSF Secreting Leukemia Cell Vaccinations after Allogeneic Reduced-Intensity Peripheral Blood Stem Cell Transplantation (SCT) for Advanced Myelodysplastic Syndrome (MDS) or Refractory Acute Myeloid Leukemia (AML).

Vincent Ho, MD, Glenn Dranoff, MD, Haesook Kim, PhD, Mildred Pasek, RN, Corey Cutler, MDMPH, Edwin Alyea, MD, John Koreth, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD

Blood (2006) 108 (11): 3680.

https://doi.org/10.1182/blood.V108.11.3680.3680

Published: 2006

Journal Articles

Phase I Study of Ipilimumab (Neutralizing Monoclonal Anti-CTLA4 Antibody) To Treat Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation: Evidence of Tumor Regression without Induction of GVHD.

Asad Bashey, MD, PhD, Bridget Medina, Sue Corringham, RN, Mildred Pasek, RN, Ewa Carrier, MD, Howard Streicher, MD, Israel Lowy, MD, James R. Mason, MD, Robert J. Soiffer, MD, Edward D. Ball, MD

Blood (2006) 108 (11): 410.

https://doi.org/10.1182/blood.V108.11.410.410

Published: 2006

Journal Articles

Rituximab for steroid-refractory chronic graft-versus-host disease

Corey Cutler, David Miklos, Haesook T. Kim, Nathaniel Treister, Sook-Bin Woo, Don Bienfang, Lloyd B. Klickstein, Jesse Levin, Katherine Miller, Carol Reynolds, Rebecca Macdonell, Mildred Pasek, Stephanie J. Lee, Vincent Ho, Robert Soiffer, Joseph H. Antin, Jerome Ritz, Edwin Alyea

Blood (2006) 108 (2): 756–762.

https://doi.org/10.1182/blood-2006-01-0233

Published: 2006

Journal Articles

Phase I Study of a Neutralizing Monoclonal Anti-CTLA4 Antibody (MDX-010) in Patients with Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation.

Asad Bashey, MD, PhD, Bridget Medina, Sue Corringham, RN, Mildred Pasek, Ewa Carrier, MD, Howard Streicher, MD, Israel Lowy, MD, PhD, James Mason, MD, Robert J. Soiffer, MD, Edward D. Ball, MD

Blood (2005) 106 (11): 2017.

https://doi.org/10.1182/blood.V106.11.2017.2017

Published: 2005

Journal Articles

Rituximab Therapy for Steroid-Refractory Chronic GVHD: Safety and Efficacy Analysis.

Corey Cutler, MD MPH FRCPC, David Miklos, MD PhD, Stephanie J. Lee, MD MPH, Sook-Bin Woo, DMD, Nathaniel Treister, DMD, Don Bienfang, MD, Lloyd Klickstein, MD PhD, Jesse Levin, BA, Katherine H. Miller, BA, Carol Reynolds, PhD, Mildred Pasek, RN, Vincent Ho, MD, Jerome Ritz, MD PhD, Joseph H. Antin, MD, Robert Soiffer, MD, Edwin Alyea, MD

Blood (2004) 104 (11): 2251.

https://doi.org/10.1182/blood.V104.11.2251.2251

Published: 2004

NARROW

Autologous Whole Tumor Cell Vaccination Early After Allogeneic Stem Cell Transplantation Elicits Anti-Tumor T Cell Responses in Patients with Advanced Chronic Lymphocytic Leukemia (CLL)

CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

GM-CSF Secreting Leukemia Cell Vaccination after Allogeneic Reduced Intensity Hematopoietic Stem Cell Transplantation for Advanced Myeloid Malignancies

Clinical Trial of Therapeutic Blockade of CTLA4 with Ipilimumab in Patients with Relapse of Malignancy Following Allogeneic Hematopoietic Transplantation.

GM-CSF Secreting Leukemia Cell Vaccinations after Allogeneic Reduced-Intensity Peripheral Blood Stem Cell Transplantation (SCT) for Advanced Myelodysplastic Syndrome (MDS) or Refractory Acute Myeloid Leukemia (AML).

Phase I Study of Ipilimumab (Neutralizing Monoclonal Anti-CTLA4 Antibody) To Treat Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation: Evidence of Tumor Regression without Induction of GVHD.

Rituximab for steroid-refractory chronic graft-versus-host disease

Phase I Study of a Neutralizing Monoclonal Anti-CTLA4 Antibody (MDX-010) in Patients with Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation.

Rituximab Therapy for Steroid-Refractory Chronic GVHD: Safety and Efficacy Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only